The 2012 Annual Meeting of Stockholders ("2012 Annual Meeting") of Forest Laboratories, Inc. (the "Company") was held on August 15, 2012, where the Company's stockholders voted on the following four proposals:

1. The election of ten director nominees to serve as members of the Company's board of directors until the Company's next Annual Meeting of Stockholders or until his or her successor has been elected or appointed (Proposal 1);

2. The approval (on an advisory basis) of the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement filed on July 9, 2012 for the 2012 Annual Meeting (the "Proxy Statement") pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the 2012 Summary Compensation Table and the tabular disclosure regarding such compensation and the accompanying narrative disclosure (Proposal 2);

3. The ratification of the selection of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2013 (Proposal 3); and

4. A stockholder proposal requesting that the Board of Directors of the Company (the "Board") amend the Company's Bylaws to allow stockholders to nominate director candidates for inclusion in the Company's proxy materials.

A fifth matter scheduled to be voted upon at the 2012 Annual Meeting and described in the Proxy Statement was a stockholder proposal submitted by Icahn Capital LP and certain affiliated entities, which are a group of hedge funds led by Carl Icahn (collectively, the "Icahn Group") that would repeal any provision of the Company's Bylaws in effect at the time of the 2012 Annual Meeting that was not included in the Company's Bylaws as publicly filed prior to June 18, 2012. As no amendments have been made to the Company's Bylaws as publicly filed prior to June 18, 2012, a representative of the Icahn Group agreed to withdraw the proposal on behalf of the Icahn Group, and the Icahn Group proposal was not included in the matters voted upon at the 2012 Annual Meeting.

A preliminary voting report was produced by IVS Associates, Inc. ("IVS"), the independent inspector of elections for the 2012 Annual Meeting, certifying the following results. These results are only preliminary and are subject to change. The Company will file an amendment to this Current Report on Form 8-K to disclose the final results within four business days after they are known.

The preliminary voting totals were as follows:

Proposal 1 - Election of Directors. Each of the following ten director nominees were elected by a plurality of votes as directors for terms expiring at the Company's next Annual Meeting of Stockholders, or until his or her successor has been elected or appointed: Howard Solomon, Nesli Basgoz, M.D., Christopher J. Coughlin, Kenneth E. Goodman, Pierre Legault, Gerald M. Lieberman, Lawrence S. Olanoff, M.D., Ph.D., Lester B. Salans, M.D., Brenton L. Saunders and Peter J. Zimetbaum, M.D.

The preliminary voting results from the 2012 Annual Meeting as reported by IVS are provided below. In addition, IVS has advised the Company that there were no broker non-votes for Proposal 1.

Name                                          For      Withheld
Howard Solomon                            192,428,946 34,177,256
Nesli Basgoz, M.D.                        195,096,207 31,509,995
Christopher J. Coughlin                   195,269,038 31,337,164
Dan L. Goldwasser                         104,423,584 4,310,965
Kenneth E. Goodman                        120,285,741 4,153,828
Gerald M. Lieberman                       195,093,139 31,513,063
Lawrence S. Olanoff, M.D., Ph.D.          122,960,337 1,479,232
Lester B. Salans, M.D.                    107,675,795 1,058,754
Brenton L. Saunders                       195,263,852 31,342,350
Peter J. Zimetbaum, M.D.                  194,954,297 31,651,905
Pierre Legault (Icahn Group nominee)      113,593,738 4,277,935
Dr. Eric J. Ende (Icahn Group nominee)    48,524,206  53,642,447
Andrew J. Fromkin (Icahn Group nominee)   41,957,886  60,208,767

Proposal 2 - Advisory Vote on Executive Compensation. The stockholders approved (on an advisory basis) the compensation of the Company's named executive officers, as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the 2012 Summary Compensation Table and the tabular disclosure regarding such compensation and the accompanying narrative disclosure. IVS has advised the Company that there were no broker non-votes for Proposal 2.

For Against Abstain
183,934,926 40,974,304 1,696,971

Proposal 3 - Ratification of Independent Auditors. The stockholders ratified the appointment of BDO USA, LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending March 31, 2013. IVS has advised the Company that there were no broker non-votes for Proposal 3.

For Against Abstain
223,855,004 1,575,909 1,175,288

Proposal 4 - Stockholder Proposal Regarding Proxy Access. The stockholders rejected the stockholder proposal requesting that the Board amend the Company's Bylaws to allow stockholders to nominate director candidates for inclusion in the Company's proxy materials. IVS has advised the Company that there were no broker non-votes for Proposal 4.

For Against Abstain
21,393,262 154,609,317 50,603,622